Clinical Scorecard: Exploring the Links Between Oxidative Stress, Metacognitive Function, and Psychopathological Symptoms in Schizophrenia: A Case-Control Analysis
At a Glance
Category
Detail
Condition
Schizophrenia
Key Mechanisms
Oxidative stress abnormalities and metacognitive deficits
Target Population
Patients with schizophrenia aged 18-60 years
Care Setting
Inpatient psychiatric hospital
Key Highlights
Patients with schizophrenia exhibited significantly lower metacognitive scores compared to healthy controls.
Oxidative stress markers (SOD, CAT, GPX) were lower, while MDA was higher in patients.
Significant correlations were found between oxidative stress markers and both metacognitive and psychopathological scores.
Guideline-Based Recommendations
Diagnosis
Diagnosis of schizophrenia according to DSM-5 criteria.
Management
Consideration of oxidative stress markers in the assessment of schizophrenia.
Monitoring & Follow-up
Regular assessment of metacognitive function and oxidative stress levels in patients.
Risks
Increased oxidative stress may correlate with worse metacognitive function and more severe psychopathology.
Patient & Prescribing Data
89 patients diagnosed with schizophrenia
Oxidative stress abnormalities may influence treatment outcomes and cognitive function.
Clinical Best Practices
Incorporate assessment of oxidative stress in the clinical evaluation of schizophrenia.
Monitor metacognitive abilities to improve treatment adherence and functional outcomes.
